Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
11/08/2000 | EP1050307A1 CCR4 antagonists in sepsis |
11/08/2000 | EP1050305A1 A composition for the treatment of stomach ulcers, duodenal ulcers and ulcers of the digestive system |
11/08/2000 | EP1049770A1 Secreted proteins and polynucleotides encoding them |
11/08/2000 | EP1049717A2 Antibodies against human il-12 |
11/08/2000 | EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
11/08/2000 | EP1049700A1 Chemokine receptor antagonists and methods of use therefor |
11/08/2000 | EP1049699A1 Azolo triazines and pyrimidines |
11/08/2000 | EP1049694A1 Benzothiadiazoles and derivatives |
11/08/2000 | EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS |
11/08/2000 | EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
11/08/2000 | EP1049679A2 Sulphonamide derivatives for treatment of cns disorders |
11/08/2000 | EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
11/08/2000 | EP1049675A1 Chemokine receptor antagonists and methods of use therefor |
11/08/2000 | EP1049662A1 Inhibitors of alpha4 mediated cell adhesion |
11/08/2000 | EP1049472A1 Antagonists of gonadotropin releasing hormone |
11/08/2000 | EP1049467A1 Celecoxib compositions |
11/08/2000 | EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound |
11/08/2000 | CN1272877A Feed product |
11/08/2000 | CN1272846A 8-substituted-9H-1,3-dioxolo/4,5-h/2,3/benzodiazepine derivatives, as Ampa/kainate receptor inhibitors |
11/08/2000 | CN1272841A Novel lactam metalloprotease inhibitors |
11/08/2000 | CN1272791A Pharmaceutical preparation comprising lactobacillus casei phamnosus |
11/08/2000 | CN1272789A Pharmaceutical compositions for oral administration of molecular iodine |
11/08/2000 | CN1272373A Navel-mounting adhesive plaster for curing cirrhosis of liver and intractable ascites |
11/08/2000 | CN1272367A Preparation of body-nourishing honey pill food |
11/08/2000 | CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands |
11/08/2000 | CN1058175C Traditional Chinese medicine for treating constipation |
11/08/2000 | CN1058173C Traditional Chinese medicine preparation for curing hepatic disease and gallstones |
11/08/2000 | CN1058168C Medicine for curing stomach disease and preparing method thereof |
11/08/2000 | CN1058165C Chinese drugs preparation for curing hepatitis B and its preparing method |
11/08/2000 | CN1058163C Medicine for curing hepatitis B |
11/08/2000 | CN1058157C Stomach medicine composition |
11/07/2000 | US6143785 Inflammatory bowel disease with alkanoyl carnitine in solution |
11/07/2000 | US6143783 Amino acids |
11/07/2000 | US6143771 Benzimidazole derivative drugs |
11/07/2000 | US6143761 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy |
11/07/2000 | US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
11/07/2000 | US6143743 Treatment of nervous system disorders |
11/07/2000 | US6143306 Methods for treating pancreatic disorders |
11/07/2000 | US6143302 Headache and colic relief composition with asafetida and method of use thereof |
11/07/2000 | CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them |
11/02/2000 | WO2000065054A2 Human membrane-associated proteins |
11/02/2000 | WO2000065031A1 Human cell line showing stable expression of cytochromes p450 |
11/02/2000 | WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
11/02/2000 | WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
11/02/2000 | WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors |
11/02/2000 | WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
11/02/2000 | WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
11/02/2000 | WO2000064538A1 Products and methods for brachytherapy |
11/02/2000 | WO2000064486A2 Enzymatically activated polymeric drug conjugates |
11/02/2000 | WO2000064478A1 Preventives/remedies for liver diseases |
11/02/2000 | WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
11/02/2000 | WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis |
11/02/2000 | WO2000064453A1 Intestinal fermentation sulfide deodorizers |
11/02/2000 | WO2000064444A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives |
11/02/2000 | WO2000064436A1 Methods of delivery of cetyl myristoleate |
11/02/2000 | WO2000064430A1 Apoptosis inhibitors |
11/02/2000 | WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
11/02/2000 | WO2000064273A1 Complete feed for fish larvae and method for preparing same |
11/02/2000 | WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
11/02/2000 | WO2000042987A3 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
11/02/2000 | WO2000040714A3 Therapeutic phosphodiesterase inhibitors |
11/02/2000 | WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
11/02/2000 | WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
11/02/2000 | WO2000039136A3 Human brainiac-5 |
11/02/2000 | WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
11/02/2000 | WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
11/02/2000 | WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
11/02/2000 | EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses |
11/02/2000 | EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
11/02/2000 | EP1048297A2 Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation |
11/02/2000 | EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
11/02/2000 | EP1047785A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
11/02/2000 | EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
11/02/2000 | EP1047688A1 Thiophene nitrone compounds |
11/02/2000 | EP1047683A1 Thioether furan nitrone compounds |
11/02/2000 | EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
11/02/2000 | EP1047675A1 Chemokine receptor antagonists and methods of use therefor |
11/02/2000 | EP1047665A1 Matrix metalloprotease inhibitors |
11/02/2000 | EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use |
11/02/2000 | EP1047426A1 Use of methylnaltrexone and related compounds |
11/02/2000 | EP1047395A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
11/02/2000 | EP0812207B1 Morphogen-induced dentine regeneration |
11/02/2000 | DE19918210A1 Gelled milk composition useful for treating intestinal inflammation containing colostral protective factors, obtained by treating colostrum or lactoserum with thickening and/or gelling agent, |
11/02/2000 | DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk |
11/02/2000 | CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
11/02/2000 | CA2371064A1 Methods of delivery of cetyl myristoleate |
11/02/2000 | CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis |
11/02/2000 | CA2370590A1 Agent for suppressing the odors of sulfides formed through fermentation in the large intestine |
11/02/2000 | CA2370581A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives |
11/02/2000 | CA2370365A1 Human cell line showing stable expression of cytochromes p450 |
11/02/2000 | CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
11/02/2000 | CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
11/02/2000 | CA2370195A1 Human membrane-associated proteins |
11/02/2000 | CA2369999A1 Enzymatically activated polymeric drug conjugates |
11/02/2000 | CA2369951A1 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
11/02/2000 | CA2367980A1 Complete feed for fish larvae and method for preparing same |
11/02/2000 | CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
11/01/2000 | CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition |